The halt is temporary, with the Leiden plant expected to start making the vaccine again after a few months, the NYT report said. J&J currently has millions of doses of its COVID-19 vaccine in inventory and it continues to provide all its fill-and-finish sites, including Aspen, with drug substance required to produce its shot, the company said in an email.
